|
|
Robert L. Martuza
J Clin Invest. 2000;
105(7):841
doi:10.1172/JCI9744
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Oncolytic virotherapy reaches adolescence
Adrienne M. Hammill, Joseph Conner, Timothy P. Cripe |
Pediatric Blood & Cancer |
2010 |
.
|
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Kengo Saito, Hiroshi Shirasawa, Naohisa Isegawa, Masashi Shiiba, Katsuhiro Uzawa, Hideki Tanzawa |
Oral Oncol |
2009 |
.
|
Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
Mark A Currier, Rebecca A Gillespie, Nancy M Sawtell, Yonatan Y Mahller, Greg Stroup, Margaret H Collins, Hirokazu Kambara, E Antonio Chiocca, Timothy P Cripe |
Mol Ther |
2008 |
.
|
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
J Foloppe, J Kintz, N Futin, A Findeli, P Cordier, Y Schlesinger, C Hoffmann, C Tosch, J-M Balloul, P Erbs |
Gene Ther |
2008 |
.
|
Employing Tumor Hypoxia for Oncolytic Therapy in Breast Cancer
Yun Shin Chun, Prasad S. Adusumilli, Yuman Fong |
J Mammary Gland Biol Neoplasia |
2006 |
.
|
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer
Maya Shmulevitz, Paola Marcato, Patrick W K Lee |
Oncogenes |
2005 |
.
|
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
S Varghese, S D Rabkin, R Liu, P G Nielsen, T Ipe, R L Martuza |
Cancer Gene Ther |
2005 |
.
|
Gene Therapy and Virotherapy of Gastric Cancer: Preclinical Results and Clinical Developments
Daniëlle A.M. Heideman |
Dig Dis |
2004 |
.
|
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers
Hironaga Kamiyama, Kunikazu Kurosaki, Masanori Kurimoto, Toyomasa Katagiri, Yusuke Nakamura, Masahiko Kurokawa, Hitoshi Sato, Shunro Endo, Kimiyasu Shiraki |
Cancer Sci |
2004 |
.
|
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10
Osamu Teshigahara, Fumi Goshima, Kazumasa Takao, Shin-ichi Kohno, Hideto Kimata, Akimasa Nakao, Yukihiro Nishiyama |
J Surg Oncol |
2004 |
.
|
Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin
John T. Mullen, James M. Donahue, Soundararajalu Chandrasekhar, Sam S. Yoon, Wenbiao Liu, Lee M. Ellis, Hideo Nakamura, Hideki Kasuya, Timothy M. Pawlik, Kenneth K. Tanabe |
Cancer |
2004 |
.
|
Viral Oncolysis for Malignant Liver Tumors
John T. Mullen, Kenneth K. Tanabe |
Ann Surg Oncol |
2003 |
.
|
Replication-Selective Viruses for Cancer Treatment
Lynda K. Hawkins, David Kirn |
Encyclopedia of Cancer |
2002 |
.
|
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications
S. J. Advani, R. R. Weichselbaum, R. J. Whitley, B. Roizman |
Clin Microbiol Infect |
2002 |
.
|
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer
A. Hasenburg, D.C. Fischer, X.-W. Tong, A. Rojas-Martinez, C. Nyberg-Hoffman, M. Orlowska-Volk, P. Kohlberger, R.H. Kaufman, I. Ramzy, E. Aguilar-Cordova, D.G. Kieback |
International Journal of Gynecological Cancer |
2002 |
.
|
Neeti Bharatan, Mark Currier, Timothy Cripe |
Journal of Pediatric Hematology/Oncology |
2002 |
.
|
John Mullen, Hideki Kasuya, Sam Yoon, Nancy Carroll, Timothy Pawlik, Soundararajalu Chandrasekhar, Hideo Nakamura, James Donahue, Kenneth Tanabe |
Ann Surg |
2002 |
.
|
Oncolytic Virus Therapy Using Genetically Engineered Herpes Simplex Viruses
Tomoki Todo |
Human Cell |
2002 |
.
|
Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium
N. D. Doolittle, C. P. Anderson, W. A. Bleyer, J. G. Cairncross, T. Cloughesy, S. L. Eck, P. Guastadisegni, W. A. Hall, L. L. Muldoon, S. J. Patel, D. Peereboom, T. Siegal, E. A. Neuwelt |
Neuro Oncology |
2001 |
.
|
Oncolytic viruses and cancer therapy
Kara L. Norman, Faris Farassati, Patrick W.K. Lee |
Cytokine Growth Factor Rev |
2001 |
.
|
|
|
|